Initial studies have provided evidence that p53 activity is lacking in many neuroblastomas, for instance, by cytoplasmic sequestration of wild-type p53 in undifferentiated neuroblastomas that leads to impaired G1 arrest in response to DNA damage [40]. The gene discussed is TP53; the disease is neuroblastoma.